GlassScriptPhysician profile
Moh'D Sbeih
NPI 1912273962
$11,372.86
in general payments reported to CMS, 2019-2025
7 companies · $1,907 in 2025
The $1,907 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,818 · 2022: $1,663 · 2023: $4,286 · 2024: $1,700 · 2025: $1,907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,500 · Travel and Lodging: $3,221 · Food and Beverage: $1,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,500.00 |
| Travel and Lodging | $3,221.46 |
| Food and Beverage | $1,171.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,864.70 | 2023-2025 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Medical Device Business Services, INC. | $3,480.21 | 2019-2022 | |
| Davol INC. | $1,690.99 | 2025 | Phasix Mesh |
| Medtronic, INC. | $163.36 | 2023 | Signia |
| Novo Nordisk INC | $117.77 | 2024 | Wegovy |
| Integra Lifesciences Corporation | $38.58 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Takeda Pharmaceuticals U.S.A., INC. | $17.25 | 2024 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moh'D Sbeih listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.